A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly.
Looking at options history for Eli Lilly (NYSE:LLY) we detected 35 strange trades.
If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 62% with bearish.
From the overall spotted trades, 31 are puts, for a total amount of $1,831,869 and 4, calls, for a total amount of $844,911.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $250.0 to $340.0 for Eli Lilly over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $250.0 to $340.0 in the last 30 days.
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|
LLY | CALL | TRADE | NEUTRAL | 06/17/22 | $300.00 | $535.0K | 4.0K | 2 |
LLY | CALL | SWEEP | BEARISH | 07/15/22 | $340.00 | $204.3K | 555 | 5 |
LLY | PUT | SWEEP | BEARISH | 08/19/22 | $260.00 | $134.0K | 2.5K | 3.2K |
LLY | PUT | SWEEP | BEARISH | 08/19/22 | $260.00 | $121.3K | 2.5K | 2.2K |
LLY | PUT | SWEEP | BEARISH | 08/19/22 | $260.00 | $107.9K | 2.5K | 2.9K |
Where Is Eli Lilly Standing Right Now?
- With a volume of 1,599,982, the price of LLY is down -1.36% at $299.14.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 53 days.
What The Experts Say On Eli Lilly:
- JP Morgan has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $355.
- SVB Leerink downgraded its action to Outperform with a price target of $341
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.